ASSET PURCHASE AGREEMENT between SPECTRUM PHARMACEUTICALS, INC. and PAR PHARMACEUTICAL, INC. dated as of May 6, 2008Asset Purchase Agreement • August 11th, 2008 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), is hereby entered into as of May 6, 2008 (the “Execution Date”), by and between Spectrum Pharmaceuticals, Inc., a Delaware corporation, with offices located at 157 Technology Drive, Irvine, California 92618 (the “Spectrum”), and Par Pharmaceutical, Inc., a Delaware corporation having its office at 300 Tice Boulevard, 3rd Floor, Woodcliff Lake, NJ 07677 (the “Par”). Spectrum and Par may each be referred to herein individually as a “Party” and collectively as the “Parties.”
CONSULTING AGREEMENTConsulting Agreement • August 11th, 2008 • Spectrum Pharmaceuticals Inc • Pharmaceutical preparations • California
This Consulting Agreement (the “Agreement”) is effective as of this 1st day of July, 2008 (the “Effective Date”), by and between Spectrum Pharmaceuticals, Inc. (“Spectrum”) located at 157 Technology Dr., Irvine California 92618, USA, and Luigi Lenaz, M.D. (“Consultant”), residing at .
ContractSpectrum Pharmaceuticals Inc • August 11th, 2008 • Pharmaceutical preparations • California
THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY OR ACQUIRABLE UPON EXERCISE HEREOF HAVE NOT REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, ASSIGNED OR TRANSFERRED, IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT REGISTRATION UNDER SAID ACT IS NOT REQUIRED.
